Last reviewed · How we verify

NCT03390439

Treatment of Atrofic Striae With Percutaneous Collagen Induction Therapy Versus Fractional Nonablative Laser

Completed NA Last updated 1 August 2018
What this trial tests

NA trial testing Nd-Yap 1340nm laser in Striae Distensae in 20 participants. Completed in 20 April 2018.

Timeline
1 July 2017
Primary endpoint
10 April 2018
20 April 2018

Quick facts

Lead sponsorHospital de Clinicas de Porto Alegre
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment20
Start date1 July 2017
Primary completion10 April 2018
Estimated completion20 April 2018
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Hospital de Clinicas de Porto Alegre

Who can join

18 and older, female only, with Striae Distensae. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As atrophic striae are common dermatological conditions. Various therapeutic modalities have been employed in the treatment of striae distensae, mainly in striae rubra. There are few studies that include the treatment of striae alba. The non-ablative fractionated laser and, more recently, microneedling are two distinct treatments, but they are widely used in dermatologist practice. The present randomized clinical trial is aimed at evaluating and evaluating the response of microneedle and fractional non-ablative laser Nd-yap 1340 in the treatment of abdominal striae alba.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of Microneedling Versus Fractional Non-ablative Laser to Treat Striae Alba: A Randomized Study.
    Naspolini AP, Boza JC, da Silva VD, Cestari TF. · · 2019 · cited 23× · PMID 30618025 · DOI 10.1007/s40257-018-0415-0

Verify or expand the search:

Other Hospital de Clinicas de Porto Alegre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03390439.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing